A single blind, multicenter, randomized controlled trial to evaluate the effectiveness and cost of a novel nutraceutical (LopiGLIK®) lowering cardiovascular disease risk
2018 ◽
Vol Volume 10
◽
pp. 601-609
◽
2014 ◽
Vol 100
(1)
◽
pp. 88-97
◽
2013 ◽
Vol 74
(07)
◽
pp. e655-e662
◽
2020 ◽
Vol 11
◽
pp. 215013272092271
◽
2015 ◽
Vol 47
(6)
◽
pp. 523-530
◽